2017 annual financial data

Fulcrum Therapeutics, Inc. 2017 Operating margin

Fulcrum Therapeutics, Inc. 2017 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -22,993,000 USD and net income was -22,964,000 USD.
Operating cash flow was -20,074,000 USD.

Get free Fulcrum Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-22,993,000 USD
Net income
-22,964,000 USD
Operating cash flow
-20,074,000 USD